In this month's webinar, Lindsey Szczepanski, NP, will explore a critical yet often overlooked aspect of endometriosis – progesterone resistance. She will delve into the mechanisms behind progesterone resistance, its implications for disease progression and management, and potential avenues for new therapeutic strategies. Understanding progesterone resistance is crucial for developing more targeted and effective treatments for women living with endometriosis.

In this webinar you will learn more about:

• How progesterone resistance impacts endometriosis
• How progesterone and estrogen receptor activity influences disease progression and presentation
• What testing is available for diagnosis and how DUTCH testing can guide treatment selection
• Review of common, investigational, and evidence-based holistic treatments for endometriosis
• And so much more

Key Moments

00:00 Introduction to Endometriosis and Progesterone Resistance

02:51 Understanding Endometriosis: Symptoms and Diagnosis

06:10 The Role of Hormones in Endometriosis

09:03 Diagnosis and Treatment Options for Endometriosis

11:59 Surgical Considerations in Endometriosis Management

14:58 Utilizing Dutch Testing in Endometriosis Care

17:50 Case Studies: Analyzing Hormonal Patterns

20:54 Progesterone Resistance: A Deeper Dive

24:11 Understanding Progesterone Receptors and Their Impact

29:45 Understanding Progesterone Receptors in Endometriosis

32:07 The Relationship Between Estrogen and Progesterone

35:55 Mechanisms of Progesterone Resistance

38:30 Exploring Treatment Options for Endometriosis

44:52 Innovative Therapies and Multi-System Approaches

50:46 Integrative Strategies for Managing Endometriosis

Please Note: The contents of this video are for educational and informational purposes only. The information is not to be interpreted as, or mistaken for, clinical advice. Please consult a medical professional or healthcare provider for medical advice, diagnoses, or treatment.

Disclaimer: Special offer of 50% OFF first five kits is invalid 60 days after new provider registration.